Clinical Trial Update: Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interleukin-1 blockade for cardiac sarcoidosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis

Drugs mentioned

• Interleukin-1 blockade

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Cardiac Sarcoidosis | Phase 2 | Status: COMPLETED | Results posted: 2025-08-07